ePData

ePData—an integrated DCT solution—reduces patient burden and promotes high-quality, rapid clinical research.

Key Features:
eCOA (Electronic Clinical Outcome Assessment): With advantages such as real-time data collection and no transcription required, it has become a key digital tool for implementing a patient-centric approach.
ePDiary (Electronic Diary): Compared to paper diaries, it better meets the internationally recognized ALCOA+ data quality standards, with compliance rates exceeding 90%.
ePConsent (Electronic Informed Consent): Through multimedia and remote access, it enables patients to more easily and fully understand the content of informed consent, improving the patient experience and implementing a patient-centric approach to drug development.
TeleVisit (Remote Visit): Through remote and online participation, more patients can participate in clinical research. Unrestricted by time and location, it enhances the patient experience, reduces patient burden, and increases the diversity of clinical research sample sizes.
ePLink (Wearable Device Connectivity): Real-time synchronization of device data facilitates objective patient data collection. When monitoring and reporting safety events, wearable devices can promptly transmit collected data to researchers, ensuring patient safety.

The app is primarily divided into a subject-side (mobile) and a visitor-side (pad):

The subject-side is primarily used by subjects participating in clinical studies to collect eCOA (electronic clinical outcome assessment) and eDiary (electronic diary) data.

The visitor-side is primarily used by researchers and data managers in clinical studies to review and manage collected eCOA and eDiary data, and to evaluate clinical study efficacy and indicators.

Our products are dedicated to empowering China with advanced digital and AI technologies to advance digital clinical research.